Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

Over the past few weeks, the Trump administration has introduced sweeping changes across the federal government that have impacted the federal ...

In statements and interviews with The Crimson, nine life sciences researchers at Harvard — from the Harvard School of Public ...

Of course the effects will vary across research institutions, as institutions differ markedly in their operating models and ...

The National Institutes of Health’s Office of the Director issued a policy change notice Feb. 7, announcing that the standard rate of indirect costs would be 15% for all current and future grants. The ...

On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.

"Without careful consideration of the impact of these changes, we risk long-term damage" to medical research, writes Dr. George Weiner.

The National Institutes of Health (NIH) is the largest single source of health care research funding in the U.S. The Trump ...

Biomedical research in the U.S. is world-class in part because of a long-standing partnership between universities and the ...

"The NIH’s new 15% cap on indirect costs threatens U.S. biomedical research by reducing funds for vital infrastructure, labs, ...